Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, Epac1, as a key driver of idiopathic pulmonary fibrosis (IPF), a chronic ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The CAAT governance board recommends transitioning from the COPD Assessment Test to the CAAT and using it for patients with ...

Of 14 metabolites identified, 2 appeared to have “robust” causal relationships with idiopathic pulmonary fibrosis.

Heat therapies such as hot tub and sauna are trendy right now. University of Oregon doctoral student Jessica Atencio led a ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, Epac1, as a key driver ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

The correspondence of Joan B Soriano and Alberto Ruano-Ravina deserves timely praise, highlighting the threat that predatory ...

"We're now able to see the invisible," says Dr. Bradley Richmond, a pulmonologist who along with Dr. Michael Lester co-led the study. "XV LVAS technology gives us a window into parts of the lung we've ...

A recent national study revealed ongoing symptom burden and communication gaps in COPD care, and provided physicians with actionable improvement strategies.

Psilocybin has slowed down the aging process in cells and mice. It may be able to scale up to humans and help slow diseases ...